Yondelis trabectedin: Updated Phase III data

Updated data from the open-label, international Phase III SAR3007 trial in 577 patients with advanced liposarcoma or leiomyosarcoma who were previously treated with an anthracycline and >=1 additional chemotherapy

Read the full 298 word article

How to gain access

Continue reading with a
two-week free trial.